Vivo Bio Tech Limited
BSE: VIVOBIOT.BO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Bombay Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Alangudi Sankaranarayanan
- Employees
- 161
- Headquarters
- Hyderabad, India
- IPO year
- 2024
- Market cap
- ₹497.9M
- Website
- http://www.vivobio.com
Loading VIVOBIOT…
Loading profile data…Frequently asked questions about VIVOBIOT
What does Vivo Bio Tech Limited (VIVOBIOT.BO) do?
Vivo Bio Tech Ltd. engages in the provision of drug development and discovery services. It offers services in the areas of vivo and vitro toxicity studies, Pharmacological investigations, Pharmacokinetic and toxicokinetic studies, Genotoxicity screening and Analytical services. The firm operates through Bio Agriculture and Industrial segments. T...
Where does VIVOBIOT.BO trade?
Vivo Bio Tech Limited (VIVOBIOT.BO) trades on the Bombay Stock Exchange.
What sector is VIVOBIOT.BO in?
Vivo Bio Tech Limited (VIVOBIOT.BO) operates in the Healthcare sector, specifically in the Medical - Distribution industry.
Who is the CEO of Vivo Bio Tech Limited?
Alangudi Sankaranarayanan is the chief executive officer of Vivo Bio Tech Limited (VIVOBIOT.BO).
Where is Vivo Bio Tech Limited headquartered?
Vivo Bio Tech Limited is headquartered in India.
Does VIVOBIOT.BO pay a dividend?
Vivo Bio Tech Limited (VIVOBIOT.BO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VIVOBIOT.BO go public?
Vivo Bio Tech Limited (VIVOBIOT.BO) completed its initial public offering in 2024.